333 related articles for article (PubMed ID: 16971390)
1. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance.
Siri P; Candela N; Zhang YL; Ko C; Eusufzai S; Ginsberg HN; Huang LS
J Biol Chem; 2001 Dec; 276(49):46064-72. PubMed ID: 11598138
[TBL] [Abstract][Full Text] [Related]
3. An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat.
Yamazaki T; Shiraishi S; Kishimoto K; Miura S; Ezaki O
J Nutr Biochem; 2011 Jun; 22(6):543-53. PubMed ID: 20801631
[TBL] [Abstract][Full Text] [Related]
4. Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.
Qiu W; Federico L; Naples M; Avramoglu RK; Meshkani R; Zhang J; Tsai J; Hussain M; Dai K; Iqbal J; Kontos CD; Horie Y; Suzuki A; Adeli K
Hepatology; 2008 Dec; 48(6):1799-809. PubMed ID: 19026012
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.
Schadinger SE; Bucher NL; Schreiber BM; Farmer SR
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1195-205. PubMed ID: 15644454
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
7. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
8. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase.
Miyake JH; Doung XD; Strauss W; Moore GL; Castellani LW; Curtiss LK; Taylor JM; Davis RA
J Biol Chem; 2001 Jun; 276(26):23304-11. PubMed ID: 11323427
[TBL] [Abstract][Full Text] [Related]
9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
10. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
11. Pistachio Consumption Prevents and Improves Lipid Dysmetabolism by Reducing the Lipid Metabolizing Gene Expression in Diet-Induced Obese Mice.
Terzo S; Caldara GF; Ferrantelli V; Puleio R; Cassata G; Mulè F; Amato A
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513740
[TBL] [Abstract][Full Text] [Related]
12. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
J Obes; 2013; 2013():296537. PubMed ID: 23401753
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.
Schroeder-Gloeckler JM; Rahman SM; Janssen RC; Qiao L; Shao J; Roper M; Fischer SJ; Lowe E; Orlicky DJ; McManaman JL; Palmer C; Gitomer WL; Huang W; O'Doherty RM; Becker TC; Klemm DJ; Jensen DR; Pulawa LK; Eckel RH; Friedman JE
J Biol Chem; 2007 May; 282(21):15717-29. PubMed ID: 17387171
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein metabolism in human apolipoprotein B(100) transgenic/brown adipose tissue deficient mice: a model of obesity-induced hyperinsulinemia.
Ehlers SJ; Larson SM; Rasmussen HE; Park YK; Lee JY
Appl Physiol Nutr Metab; 2011 Jun; 36(3):313-22. PubMed ID: 21574779
[TBL] [Abstract][Full Text] [Related]
15. Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice.
Jung UJ; Park YB; Kim SR; Choi MS
PLoS One; 2012; 7(11):e49030. PubMed ID: 23145054
[TBL] [Abstract][Full Text] [Related]
16. RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.
Cui XB; Luan JN; Chen SY
J Biol Chem; 2015 Aug; 290(33):20387-95. PubMed ID: 26134570
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake.
Labrie M; Lalonde S; Najyb O; Thiery M; Daneault C; Des Rosiers C; Rassart E; Mounier C
PLoS One; 2015; 10(6):e0130230. PubMed ID: 26083030
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling.
Moon BC; Hernandez-Ono A; Stiles B; Wu H; Ginsberg HN
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):236-46. PubMed ID: 22155452
[TBL] [Abstract][Full Text] [Related]
19. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
[TBL] [Abstract][Full Text] [Related]
20. Hepatic steatosis with relation to increased expression of peroxisome proliferator-activated receptor-γ in insulin resistant mice.
Satoh H; Ide N; Kagawa Y; Maeda T
Biol Pharm Bull; 2013; 36(4):616-23. PubMed ID: 23386130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
